An updated medical position statement of the North American society for pediatric gastroenterology and nutrition

Journal of Pediatric Gastroenterology and Nutrition

Volumn 31, Issue 3, 2000, Pages 232-233

  Shulman, R J ^a   Boyle, J T ^a   Colletti, R B ^a   Friedman, R ^a   Heyman, M B ^a   Kearns, G ^a   Kirschner, B S ^a   Levy, J ^a   Mitchell, A A ^a   Van Hare, G ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; CLARITHROMYCIN; ERYTHROMYCIN; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MACROLIDE; MICONAZOLE; PYRROLE DERIVATIVE;

DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG LABELING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HUMAN; MEDICAL SOCIETY; PATIENT MONITORING; PEDIATRICS; PRIORITY JOURNAL; SHORT SURVEY;

CHILD; CISAPRIDE; GASTROINTESTINAL AGENTS; HUMANS; SAFETY; TREATMENT OUTCOME;

EID: 0033865093     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200009000-00005     Document Type: Short Survey

References (8)

1. Use of cisapride in children. A medical position statement of the North American for Pediatric Gastroenterology and Nutrition
2. Cisapride in the control of symptoms in infants with gastroesophageal reflux: A randomized, double-blind, placebo-controlled trial
3. Cisapride for the treatment of constipation in children: A double-blind study
4. Randomized controlled trial of cisapride in preterm infants
5. Effect of cisapride on the QT interval in infants with gastroesophageal reflux
6. Cisapride: A survey of the frequency of use and adverse events in premature newborns
7. Effects of cisapride on QT interval in children